Check-Cap Announces Positive Results from U.S. Pilot Study of C-Scan® System
- Monday, December 30, 2019, 7:00
- Finance
- Add a comment
ISFIYA, Israel, Dec. 30, 2019 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestible…
About the Author
adminasapcorp has written 39089 stories on this site.